Alliqua BioMedical, Inc. Announces Termination of its Agreement to Acquire Soluble Systems, LLC
Feb 28, 2017 12:30 pm UTC| Business
YARDLEY, Pa., Feb. 28, 2017 -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced the termination...
Cutera to Present at the 29th Annual ROTH Conference
Feb 28, 2017 12:30 pm UTC| Business
BRISBANE, Calif., Feb. 28, 2017 -- Cutera, Inc. (Nasdaq:CUTR), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, announced today that Ron Santilli, Chief Financial...
KemPharm, Inc. to Report Fourth Quarter and Year End 2016 Results
Feb 28, 2017 12:30 pm UTC| Business
Conference Call and Live Audio Webcast with Slide Presentation Scheduled forMarch 9th, 2017, 4:30 p.m. ET CORALVILLE, Iowa, Feb. 28, 2017 -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical...
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
Feb 28, 2017 12:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2017 -- Cytokinetics, Inc. (Nasdaq:CYTK) today announced that it is joining the global initiative with the European Organisation for Rare Diseases (EURORDIS) and the National...
Lightbridge Selected to Present at CleanEquity Monaco 2017 - The 10th Anniversary
Feb 28, 2017 12:30 pm UTC| Business
RESTON, Va., Feb. 28, 2017 -- Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear fuel technology company, today announced that it will present at CleanEquity Monaco 2017 on March 9th 10th at the Fairmont Monte...
Feb 28, 2017 12:30 pm UTC| Business
CAMBRIDGE, Mass., Feb. 28, 2017 -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced the company is scheduled to present...
Neos Therapeutics to Present at the Cowen and Company 37th Annual Health Care Conference
Feb 28, 2017 12:30 pm UTC| Business
DALLAS and FORT WORTH, Texas, Feb. 28, 2017 -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its...